http://www.pmprb-cepmb.gc.ca/view.asp?ccid=957 en-ca In this issue: Update on Guideline Reform, NPDUIS update: Engagement activities, New and upcoming publications, 2019 Human Drug Advisory Panel Meetings - Update, 2019 CPI-Based Price-Adjustment Factors for Patented Medicines, Summary of the Board’s October 2018 Meeting http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1412&lang=en wed, 31 oct 2018 00:00:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1412&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca In this issue: New Board Members Appointed, Update on Guideline Reform, Supreme Court Declines to Grant Leave to Review Decision Reiterating Constitutional Validity of the PMPRB, NPDUIS update: Engagement activities, New and upcoming publications, First Quarter 2019 Human Drug Advisory Panel Meeting, Voluntary Compliance Undertakings http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1386&lang=en thurs, 9 aug 2018 00:00:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1386&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca In this issue: Next steps on Guideline reform, NPDUIS update: Engagement activities, NPDUIS update: Engagement activities, New and upcoming publications, Voluntary Compliance Undertakings, Summary of the Board’s April 2018 meeting http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1369&lang=en thurs, 10 may 2018 00:00:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1369&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca In this issue: Message from the Chairperson: the PMPRB turns 30, Update on PMPRB framework modernization, PMPRB Hearing Panel issues decision in Soliris case, PMPRB bids farewell to Elaine McGillivray, NPDUIS update, new and upcoming publications, and summary of the Board’s September 2017 meeting. http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1355&lang=en wed, 7 march 2018 00:00:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1355&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca In this issue: Update on the PMPRB framework modernization, Block 5 filing requirements for Patentees, PMPRB bids farewell to board member Normand Tremblay, 2018 HDAP schedule, NPDUIS update, new and upcoming publications, and summary of the Board’s May 2017 meeting. http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1321&lang=en Mon, 31 July 2017 00:00:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1321&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca In this issue: Health Canada launches consultation on potential changes to the Patented Medicine Regulations, and update on the Soliris matter, 2017 Human Drug Advisory Panel meeting rescheduled, and reminders to patentees. http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1315&lang=en Mon, 29 May 2017 19:38:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1315&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca In this issue: Vice-chairperson of the Board reappointed for a second term; hearing updates; 2017 CPI-based price adjustment factors for patented drug products; a new policy on patented generic-drug price reviews; and a reminder to patentees of the Form 3 filing deadline. http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1292&lang=en Fri, 03 Feb 2017 19:38:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1292&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca Minor error in the latest NEWSletter corrected. Please see updated article: Patentee submissions in support of the scientific review process. http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1287&lang=en Thurs, 10 Nov 2016 19:38:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1287&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca In this issue: Update on public consultations, 2015 PMPRB Annual Report highlights, hearing updates, 2017 CPI-based price-adjustment factors for patented drug products, information for patentees, and a new National Prescription Drug Utilization Information System report. http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1287&lang=en Thurs, 3 Nov 2016 19:38:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1287&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca In this issue: PMPRB bids farewell to Chairperson Mary Catherine Lindberg, Federal Court dismisses challenge to constitutionality of PMPRB, Rethinking the Guidelines: Public and stakeholder comments invited, results of the Notice and Comment period on incremental reforms to the Compendium of Policies, Guidelines and Procedures, 2017 Human Drug Advisory Panel schedule, new expression of interest process for potential outside counsel to Board Staff, new Voluntary Compliance Undertakings (Samsca, Actimmune, Cialis, Spiriva Respimat, Xalkori, and Fibristal) and summary of the Board’s May 2016 meeting. http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1271&lang=en Wed, 27 Jul 2016 00:00:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1271&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca In this issue: upcoming public consultation on PMPRB framework modernization, Form 2 filing requirements for new patented medicines, information on upcoming hearings, and the Chairperson of the Board approves four Voluntary Compliance Undertakings (Mitosol, Neoral, Apprilon, and Angiomax). http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1255&lang=en Thurs, 28 Apr 2016 00:00:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1255&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca In this issue: 2016 Consumer Price Index-based price adjustment factors for patented drug products, the recognized price source for Germany has changed to Lauer-Taxe, patentees are reminded that the deadline for filing Form 3 information on revenues and R&D expenditures is March 1, 2016, and the Chairperson of the Board approves Voluntary Compliance Undertakings for the patented medicines Dificid (fidaxomicin) and Zaxine (rifaximin). http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1231&lang=en Fri, 29 Jan 2016 00:00:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1231&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca In this issue: The PMPRB publishes its Strategic Plan and 2014 Annual Report; Federal Court of Appeal decision in salbutamol HFA; upcoming notice and comment on incremental reforms to the Compendium of Policies, Guidelines and Procedures; NPDUIS publishes New Drug Pipeline Monitor, 7^th edition and Private Drug Plans in Canada, Part 1: Generic Market 2005-2013; and the Board approves Voluntary Compliance Undertakings for the patented medicines Carnitor IV and Loprox. http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1208&lang=en Tues, 15 Dec 2015 00:00:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1208&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca In this issue: The PMPRB holds a public, pre-hearing conference in the matter of the price of the patented medicine Soliris; updates to the Compendium of Policies, Guidelines and Procedures; update on the recognized price source for Germany; and the 2016 Human Drug Advisory Panel schedule. http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1179&lang=en Thurs, 3 Dec 2015 00:00:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1179&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca In this issue: New appointments to the Human Drug Advisory Panel; NPDUIS publishes the inaugural CompassRx report; new requirements for electronic submissions by patentees on level of therapeutic improvement; and the PMPRB participates in PPRI conference in Prague. http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1168&lang=en Wed, 14 Oct 2015 00:00:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1168&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca In this issue: The PMPRB files a Notice of Hearing in the matter of the price of the patented medicine Soliris; the Board approves a Voluntary Compliance Undertaking for the patented medicine Gelnique; updates for 2014 made to the Monitoring and Evaluation Plan for the Major Changes in the Guidelines; and NPDUIS publishes Generic Drugs in Canada, 2013 and the New Drug Pipeline Monitor, 6th edition. http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1145&lang=en Wed, 14 Oct 2015 00:00:00 GMT http://www.pmprb-cepmb.gc.ca/view.asp?ccid=1145&lang=en PMPRB PMPRB.Information-Renseignements.CEPMB@pmprb-cepmb.gc.ca